Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jonathan Douxfils and Thomas Lecompte.
Jonathan Douxfils
Connection Strength
1.003
Thomas Lecompte
  1. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica. 2021 08 12.
    View in: PubMed
    Score: 0.240
  2. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol. 2021; 12:708302.
    View in: PubMed
    Score: 0.240
  3. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
    View in: PubMed
    Score: 0.236
  4. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med. 2021 Apr 16; 10(8).
    View in: PubMed
    Score: 0.059
  5. Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data. Data Brief. 2020 Dec; 33:106519.
    View in: PubMed
    Score: 0.057
  6. Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations. J Thromb Haemost. 2020 11; 18(11):3121-3124.
    View in: PubMed
    Score: 0.057
  7. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2021 01; 197:20-23.
    View in: PubMed
    Score: 0.057
  8. [Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.